Furthermore, AnxA2 interacts with galectin-3 at the cell surface, which directly induces cellular insulin resistance and associated inflammation under obese conditions by impairing insulin signaling [132,133,134]. The gene discussed is LGALS3; the disease is Insulin resistance.